Your browser doesn't support javascript.
loading
Lower response to trastuzumab emtansine in metastatic breast cancer patients with human epidermal growth factor receptor 2 immunohistochemistry score of 2 and fluorescence in situ hybridization positive compared with immunohistochemistry score of 3: a retrospective study.
Yazaki, Shu; Hashimoto, Jun; Ogita, Shin; Nakano, Eriko; Suzuki, Koyu; Yamauchi, Teruo.
  • Yazaki S; Department of Internal Medicine, Division of Medical Oncology, St. Luke's International Hospital.
  • Hashimoto J; Department of Internal Medicine, Division of Medical Oncology, St. Luke's International Hospital.
  • Ogita S; Department of Internal Medicine, Division of Medical Oncology, St. Luke's International Hospital.
  • Nakano E; Department of Internal Medicine, Division of Medical Oncology, St. Luke's International Hospital.
  • Suzuki K; Department of Pathology, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan.
  • Yamauchi T; Department of Internal Medicine, Division of Medical Oncology, St. Luke's International Hospital.
Anticancer Drugs ; 31(9): 973-978, 2020 10.
Article en En | MEDLINE | ID: mdl-32868644
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Ado-Trastuzumab Emtansina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor ErbB-2 / Ado-Trastuzumab Emtansina Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article